Aramaki Osamu, Inoue Fumihiko, Takayama Tadatoshi, Shimazu Motohide, Kitajima Masaki, Ikeda Yoshifumi, Okumura Ko, Yagita Hideo, Shirasugi Nozomu, Niimi Masanori
Department of Surgery, Teikyo University, Tokyo, Japan.
Transplantation. 2005 Mar 15;79(5):568-76. doi: 10.1097/01.tp.0000153151.16350.53.
We previously reported that intratracheal delivery of alloantigen-induced regulatory cells in mouse heart-transplantation model. Here, we investigated roles of interleukin (IL)-10 and transforming growth factor (TGF)-beta in induction and effector phases of the regulatory cells.
CBA mice were pretreated with intratracheal delivery of C57BL/10 splenocytes and administration of neutralizing anti-IL-10 or anti-TGF-beta monoclonal antibody (mAb). Seven days after the pretreatment, naive CBA mice (secondary recipients) were given adoptive transfer of splenocytes from the pretreated mice and underwent heart grafting from C57BL/10 mice. To determine roles of these cytokines in the effector phase of the regulatory cells, anti-IL-10 or anti-TGF-beta mAb was administered weekly into the secondary recipients after the adoptive transfer.
Adoptive transfer of splenocytes from CBA mice that had been pretreated with intratracheal delivery of C57BL/10 splenocytes significantly prolonged the survival of C57BL/10 allograft (median survival time [MST] 68 days) as compared with adoptive transfer from untreated CBA mice (MST 12 days). In the induction phase, anti-IL-10 mAb abrogated development of the regulatory cells that afforded prolonged allograft survival in the secondary recipients (MST 20 days), whereas anti-TGF-beta mAb did not abrogate it (MST 88 days). In the effector phase, anti-IL-10 mAb abrogated prolonged allograft survival afforded by adoptive transfer of the regulatory cells in the secondary recipients (MST 27 days), whereas anti-TGF-beta mAb did not abrogate suppressor function of the regulatory cells (MST 53 days).
IL-10 but not TGF-beta was required for generation and suppressor function of the regulatory cells induced by intratracheal delivery of alloantigen.
我们之前报道了在小鼠心脏移植模型中经气管递送同种异体抗原诱导的调节性细胞。在此,我们研究了白细胞介素(IL)-10和转化生长因子(TGF)-β在调节性细胞的诱导和效应阶段所起的作用。
对CBA小鼠进行预处理,经气管递送C57BL/10脾细胞,并给予中和性抗IL-10或抗TGF-β单克隆抗体(mAb)。预处理7天后,将来自预处理小鼠的脾细胞过继转移给未处理的CBA小鼠(二级受体),并接受来自C57BL/10小鼠的心脏移植。为了确定这些细胞因子在调节性细胞效应阶段的作用,在过继转移后每周向二级受体给予抗IL-10或抗TGF-β mAb。
与从未经处理的CBA小鼠过继转移(中位生存时间[MST]12天)相比,经气管递送C57BL/10脾细胞预处理的CBA小鼠的脾细胞过继转移显著延长了C57BL/10同种异体移植物的存活时间(MST 68天)。在诱导阶段,抗IL-10 mAb消除了调节性细胞的发育,而这种调节性细胞能使二级受体中的同种异体移植物存活时间延长(MST 20天),而抗TGF-β mAb并未消除(MST 88天)。在效应阶段,抗IL-10 mAb消除了二级受体中调节性细胞过继转移所带来的同种异体移植物存活时间延长(MST 27天),而抗TGF-β mAb并未消除调节性细胞的抑制功能(MST 53天)。
经气管递送同种异体抗原诱导的调节性细胞的产生和抑制功能需要IL-10而非TGF-β。